“Naringenin and Ketoprofen-RGD Conjugate: A Promising Treatment for Leukemia and Ovarian Cancer via Calmodulin/PDE/cAMP/PKA Pathway and Anti-Inflammatory Effects”

https://pubmed.ncbi.nlm.nih.gov/38116560

The combination of Naringenin and a ketoprofen-RGD conjugate shows potential as a treatment for leukemia and ovarian cancer, inhibiting cell proliferation through the calmodulin/PDE/cAMP/PKA pathway and exhibiting anti-inflammatory effects.